SCHEMBL5095886

SCHEMBL5095886

NN(C(=O)OC1CCCC1)c1ccc(OCc2ccc(F)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 1/20 0.51
▸ MAOB P27338 7/20 0.50
▸ PARP10 Q53GL7 1/20 0.50
▸ HRH3 Q9Y5N1 1/20 0.48
▸ S1PR5 Q9H228 1/20 0.48
▸ KCNH2 Q12809 1/20 0.47
▸ PPARA Q07869 1/20 0.46
▸ CA12 O43570 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ CA7 P43166 1/20 0.44
▸ CA9 Q16790 1/20 0.44
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ GSK3B P49841 1/20 0.43
▸ BACE1 P56817 1/20 0.43
▸ FFAR1 O14842 1/20 0.43
▸ CASP3 P42574 1/20 0.43
▸ SENP8 Q96LD8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5090765 0.81 MAOB (0.56) NR4A2MAOBPARP10PPARACA12
SCHEMBL5090872 0.81 NR4A2 (0.53) NR4A2MAOBPARP10PPARAFFAR1
SCHEMBL5090818 0.79 MAOB (0.53) NR4A2MAOBPARP10PPARACA12
SCHEMBL5096558 0.78 MAOB (0.52) NR4A2MAOBPARP10PPARACA12
SCHEMBL5090861 0.78 MAOB (0.52) NR4A2MAOBPARP10PPARACA12
SCHEMBL5089215 0.77 MAOB (0.51) NR4A2MAOBPARP10S1PR5PPARA
SCHEMBL5089208 0.77 MAOB (0.51) NR4A2MAOBPARP10PPARACA12
SCHEMBL5090749 0.77 MAOB (0.51) NR4A2MAOBPARP10HRH3S1PR5
SCHEMBL5090267 0.76 MAOB (0.50) NR4A2MAOBPARP10PPARACA12
SCHEMBL5087388 0.76 MAOB (0.50) NR4A2MAOBPARP10PPARACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 — — US claimed
US-8722929-B2 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2014-05-13 — — US disclosed
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS KCNB2, KCNJ2, KCNA2 NR4A2 851/4885MAOB 808/4885PARP10 2373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback